Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ABCLAbCellera Biologics Inc.

Nasdaq · CIK 0001703057
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts262

Identity from submissions API

NameAbCellera Biologics Inc.
CIK0001703057
TickersABCL
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationA1 British Columbia, Canada
Phone(604) 559-9005
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
150 W 4TH AVENUE
VANCOUVER
A1
V5Y 1G6
British Columbia, Canada
Mailing address
150 W 4TH AVENUE
VANCOUVER
A1
V5Y 1G6
British Columbia, Canada

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

329 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 4 FORM 4 0001834411-26-000013 9612
2026-11-13 4 FORM 4 0001834449-26-000011 5142
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-460670 005-91923 261552686 34 8885
2026-11-13 4 FORM 4 0001834411-26-000010 5508
2026-11-12 4 FORM 4 0001834449-26-000009 5457
2026-11-09 10-Q 10-Q 0001703057-26-000059 001-39781 261536530 34 6752959 1 1
2026-11-09 8-K 8-K 2.02,7.01,9.01 0001703057-26-000058 001-39781 261536292 34 3339790 1 1
2026-08-24 4 FORM 4 0001628280-26-058684 6532
2026-08-18 4 FORM 4 0001834423-26-000008 5454
2026-08-14 4 FORM 4 0001834411-26-000008 5509
2026-08-14 4 FORM 4 0001628280-26-057007 6532
2026-08-13 8-K 8-K 1.01,8.01,9.01 0001193125-26-349353 001-39781 261274141 34 616519 1 1
2026-08-13 424B5 424B5 0001193125-26-349333 333-285367 261274095 33 785844 1 1
2026-08-13 4 FORM 4 0001628280-26-056653 6210
2026-08-11 424B5 424B5 0001193125-26-344944 333-285367 261264202 33 641184
2026-08-10 8-K 8-K 7.01,9.01 0001703057-26-000053 001-39781 261256254 34 3888205 1 1
2026-08-07 8-K 8-K 8.01,9.01 0001703057-26-000049 001-39781 261255024 34 427380 1 1
2026-08-05 10-Q 10-Q 0001703057-26-000046 001-39781 261244074 34 5635131 1 1
2026-08-05 8-K 8-K 2.02,7.01,9.01 0001703057-26-000044 001-39781 261243844 34 1676758 1 1
2026-07-29 8-K 8-K 8.01,9.01 0001703057-26-000039 001-39781 261215507 34 746807 1 1
2026-07-06 4 FORM 4 0001628280-26-047400 5687
2026-07-06 3 FORM 3 0001628280-26-047399 3216
2026-07-06 4 FORM 4 0001628280-26-047396 5706
2026-07-06 8-K 8-K 5.02,9.01 0001703057-26-000037 001-39781 261155500 34 498844 1 1
2026-06-17 8-K 8-K 8.01,9.01 0001703057-26-000035 001-39781 261097323 34 690723 1 1
2026-06-12 4 FORM 4 0001628280-26-042739 5697
2026-06-12 4 FORM 4 0001685889-26-000002 5687
2026-06-12 4 FORM 4 0001834423-26-000006 5683
2026-06-12 8-K 8-K 5.07 0001703057-26-000033 001-39781 261085626 34 142551 1 1
2026-06-11 3 FORM 3 0001628280-26-042450 498096
2026-06-05 8-K 8-K 5.02,9.01 0001703057-26-000031 001-39781 261067701 34 451142 1 1
2026-06-03 4 FORM 4 0001834411-26-000006 7940
2026-05-18 4 FORM 4 0001834423-26-000004 5452
2026-05-11 10-Q 10-Q 0001703057-26-000028 001-39781 26963481 34 5066719 1 1
2026-05-11 8-K 8-K 2.02,7.01,9.01 0001703057-26-000027 001-39781 26963316 34 3162949 1 1
2026-05-07 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-057139 005-91923 26953326 34 14482
2026-04-29 ARS ARS 0001703057-26-000023 001-39781 26914775 34 28413382
2026-04-29 DEFA14A DEFA14A 0001703057-26-000021 001-39781 26913929 34 338693
2026-04-29 DEF 14A DEF 14A 0001703057-26-000020 001-39781 26913890 34 2976685 1 1
2026-03-02 4 FORM 4 0001834449-26-000004 5241
2026-02-27 4 FORM 4 0001834449-26-000002 5242
2026-02-27 4 FORM 4 0001834411-26-000004 5295
2026-02-24 S-8 S-8 0001703057-26-000013 333-293694 26672508 33 820639 1 1
2026-02-24 10-K 10-K 0001703057-26-000012 001-39781 26672345 34 19363816 1 1
2026-02-24 8-K 8-K 2.02,7.01,9.01 0001703057-26-000010 001-39781 26671759 34 1931180 1 1
2026-01-14 8-K 8-K 7.01,9.01 0001703057-26-000003 001-39781 26533915 34 4495495 1 1
2026-01-05 4 FORM 4 0001834411-26-000002 5564
2026-01-05 4 FORM 4 0001834412-26-000002 5577
2026-01-05 4 FORM 4 0001834424-26-000002 5542
2026-01-05 4 FORM 4 0001834418-26-000002 5575
2025-12-19 4 FORM 4 0001685889-25-000008 5519
2025-12-19 3 FORM 3 0001685889-25-000006 5631
2025-12-19 4 FORM 4 0001834449-25-000004 4930
2025-12-18 8-K 8-K 7.01,9.01 0001703057-25-000034 001-39781 251582735 34 511146 1 1
2025-11-28 8-K 8-K 4.01,9.01 0001703057-25-000032 001-39781 251534975 34 291942 1 1
2025-11-26 4 FORM 4 0001834423-25-000004 5243
2025-11-12 8-K 8-K 5.02,9.01 0001703057-25-000029 001-39781 251471469 34 532532 1 1
2025-11-06 10-Q 10-Q 0001703057-25-000025 001-39781 251458853 34 6040833 1 1
2025-11-06 8-K 8-K 2.02,7.01,9.01 0001703057-25-000024 001-39781 251458662 34 1406358 1 1
2025-09-10 8-K 8-K 8.01,9.01 0001703057-25-000018 001-39781 251305231 34 472051 1 1
2025-08-07 10-Q 10-Q 0001703057-25-000011 001-39781 251194801 34 5970402 1 1
2025-08-07 8-K 8-K 2.02,7.01,9.01 0001628280-25-038927 001-39781 251194592 34 1732798 1 1
2025-07-01 4 FORM 4 0001628280-25-033735 5484
2025-06-16 4 FORM 4 0001628280-25-031647 5471
2025-06-16 4 FORM 4 0001628280-25-031646 5464
2025-06-13 8-K 8-K 5.07 0001628280-25-031219 001-39781 251045582 34 142553 1 1
2025-05-30 8-K 8-K 8.01,9.01 0001628280-25-028529 001-39781 251009558 34 695942 1 1
2025-05-14 8-K 8-K 8.01,9.01 0001628280-25-025573 001-39781 25947073 34 753008 1 1
2025-05-13 8-K 8-K 8.01,9.01 0001628280-25-025006 001-39781 25939180 34 754913 1 1
2025-05-08 10-Q 10-Q 0001628280-25-023836 001-39781 25926563 34 5901262 1 1
2025-05-08 8-K 8-K 2.02,7.01,9.01 0001628280-25-023808 001-39781 25926276 34 2662800 1 1
2025-04-29 ARS ARS 0001628280-25-020746 001-39781 25888714 34 24624316
2025-04-29 DEFA14A DEFA14A 0001628280-25-020729 001-39781 25888430 34 338996
2025-04-29 DEF 14A DEF 14A 0001628280-25-020703 001-39781 25888127 34 2391598 1 1
2025-03-11 4 FORM 4 0001628280-25-012154 5249
2025-03-10 4 FORM 4 0001628280-25-011750 5247
2025-03-07 4 FORM 4 0001628280-25-011254 5249
2025-02-27 S-3ASR S-3ASR 0001193125-25-039391 333-285367 25680621 33 1343748 1 1
2025-02-27 S-8 S-8 0001628280-25-008708 333-285351 25679849 33 848346 1 1
2025-02-27 10-K 10-K 0001628280-25-008689 001-39781 25679324 34 17364089 1 1
2025-02-27 8-K 8-K 2.02,7.01,9.01 0001628280-25-008650 001-39781 25678854 34 2507847 1 1
2025-02-18 8-K 8-K 8.01 0001628280-25-005983 001-39781 25633588 34 175667 1 1
2025-01-03 4 FORM 4 0001628280-25-000237 5553
2025-01-03 4 FORM 4 0001628280-25-000235 5585
2025-01-03 4 FORM 4 0001628280-25-000233 5577
2025-01-03 4 FORM 4 0001628280-25-000232 5587
2024-12-05 4 FORM 4 0001628280-24-050097 4941
2024-11-26 4 FORM 4 0001628280-24-049327 7945
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-118908 005-91923 241462284 34 89179
2024-11-04 10-Q 10-Q 0001628280-24-045026 001-39781 241424119 34 6193880 1 1
2024-11-04 8-K 8-K 2.02,7.01,9.01 0001628280-24-045022 001-39781 241424001 34 1359260 1 1
2024-10-09 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001088875-24-000098 005-91923 241361735 34 7043
2024-09-24 4 FORM 4 0001628280-24-041217 7945
2024-08-29 4 FORM 4 0001628280-24-038829 5255
2024-08-06 10-Q 10-Q 0001628280-24-035248 001-39781 241180216 34 18763909 1 1
2024-08-06 8-K 8-K 2.02,7.01,9.01 0001628280-24-035229 001-39781 241179753 34 1938754 1 1
2024-06-24 4 FORM 4 0001628280-24-029675 9898
2024-06-24 4 FORM 4 0001628280-24-029673 5230
2024-06-24 4 FORM 4 0001628280-24-029668 5210
2024-06-24 4 FORM 4 0001628280-24-029666 5217
2024-06-13 8-K 8-K 5.07 0001628280-24-028097 001-39781 241041959 34 150615 1 1
2024-06-03 4 FORM 4 0001628280-24-026338 7945
2024-05-07 10-Q 10-Q 0001628280-24-021159 001-39781 24922822 34 5671080 1 1
2024-05-07 8-K 8-K 2.02,7.01,9.01 0001628280-24-021115 001-39781 24922329 34 1924010 1 1
2024-04-29 ARS ARS 0001628280-24-019043 001-39781 24892001 34 24254056
2024-04-29 DEFA14A DEFA14A 0001628280-24-019035 001-39781 24891858 34 336528
2024-04-29 DEF 14A DEF 14A 0001628280-24-019019 001-39781 24891419 34 2017785 1 1
2024-02-27 4 FORM 4 0001703057-24-000026 7944
2024-02-23 8-K 8-K 5.02,9.01 0001703057-24-000024 001-39781 24672214 34 696581 1 1
2024-02-20 S-8 S-8 0001703057-24-000021 333-277192 24654363 33 903465
2024-02-20 10-K 10-K 0001703057-24-000019 001-39781 24654148 34 34514838 1 1
2024-02-20 8-K 8-K 2.02,7.01,9.01 0001703057-24-000017 001-39781 24653859 34 3020952 1 1
2024-02-14 SC 13G SC 13G 0001104659-24-023719 005-91923 24638777 34 91111
2024-02-13 SC 13G/A SC 13G/A 0001193125-24-033914 005-91923 24627796 34 66180
2024-01-29 SC 13G/A AbcelleraBiologics29122023.txt 0001088875-24-000043 005-91923 24571781 34 11204
2024-01-16 4 FORM 4 0001703057-24-000008 5586
2024-01-16 4 FORM 4 0001703057-24-000006 5554
2024-01-16 4 FORM 4 0001703057-24-000004 5576
2024-01-16 4 FORM 4 0001703057-24-000002 5588
2023-12-19 4 FORM 4 0001703057-23-000049 4942
2023-11-28 8-K 8-K 8.01 0001703057-23-000047 001-39781 231447676 34 143957 1 1
2023-11-27 4 FORM 4 0001703057-23-000044 7863
2023-11-08 4 FORM 4 0001703057-23-000042 7159
2023-11-02 10-Q 10-Q 0001703057-23-000040 001-39781 231372825 34 26506059 1 1
2023-11-02 8-K 8-K 2.02,7.01,9.01 0001703057-23-000038 001-39781 231372450 34 3793145 1 1
2023-10-13 8-K 8-K 8.01 0001703057-23-000034 001-39781 231323659 34 141894 1 1
2023-09-26 4 FORM 4 0001703057-23-000032 6245
2023-09-14 4 FORM 4 0001703057-23-000030 7387
2023-08-25 4 FORM 4 0001703057-23-000027 7863
2023-08-09 4 FORM 4 0001703057-23-000024 6245
2023-08-03 10-Q 10-Q 0001703057-23-000022 001-39781 231140658 34 23953981 1 1
2023-08-03 8-K 8-K 2.02,7.01,9.01 0001703057-23-000020 001-39781 231140227 34 1837347 1 1
2023-06-20 8-K 8-K 5.07 0001703057-23-000014 001-39781 231026016 34 155593 1 1
2023-05-30 4 FORM 4 SUBMISSION 0001209191-23-032793 7976
2023-05-26 4 FORM 4 SUBMISSION 0001209191-23-032484 5235
2023-05-26 4 FORM 4 SUBMISSION 0001209191-23-032481 5161
2023-05-24 8-K 8-K 1.01,2.03,8.01,9.01 0001703057-23-000011 001-39781 23953508 34 1252743 1 1
2023-05-09 4 FORM 4 SUBMISSION 0001209191-23-028214 9930
2023-05-04 10-Q 10-Q 0001703057-23-000008 001-39781 23889747 34 6007449 1 1
2023-05-04 8-K 8-K 2.02,7.01,9.01 0001703057-23-000005 001-39781 23889494 34 4201523 1 1
2023-04-28 DEFA14A DEFA14A 0001140361-23-021665 001-39781 23867716 34 2659678
2023-04-28 DEF 14A DEF 14A 0001140361-23-021664 001-39781 23867690 34 5523880 1 1
2023-04-28 ARS ARS 0001140361-23-021660 001-39781 23867574 34 3998787
2023-04-24 SC 13D/A SC 13D/A 0001104659-23-049066 005-91923 23840720 34 109965
2023-03-13 8-K 8-K 7.01 0001564590-23-003427 001-39781 23725139 34 166072 1 1
2023-02-23 4 FORM 4 SUBMISSION 0001209191-23-012199 7944
2023-02-21 S-8 S-8 0001193125-23-043666 333-269896 23649466 33 90228
2023-02-21 10-K 10-K 0001564590-23-002128 001-39781 23649275 34 17848328 1 1
2023-02-21 8-K 8-K 2.02,7.01,9.01 0001564590-23-002126 001-39781 23649037 34 5456839 1 1
2023-02-13 SC 13G/A SEC SCHEDULE 13G 0001422849-23-000014 005-91923 23617282 34 18179
2023-02-06 SC 13G/A SC 13G/A 0001193125-23-025646 005-91923 23591123 34 68897
2023-01-18 SC 13G AbcelleraBiologics30122022.txt 0001088875-23-000005 005-91923 23532887 34 11087
2022-12-22 4 FORM 4 SUBMISSION 0001209191-22-062412 9462
2022-12-20 4 FORM 4 SUBMISSION 0001209191-22-062090 5132
2022-12-05 4 FORM 4 SUBMISSION 0001209191-22-059580 5103
2022-12-05 4 FORM 4 SUBMISSION 0001209191-22-059579 5127
2022-12-05 4 FORM 4 SUBMISSION 0001209191-22-059578 5111
2022-12-05 4 FORM 4 SUBMISSION 0001209191-22-059573 5489
2022-12-05 4 FORM 4 SUBMISSION 0001209191-22-059570 5457
2022-12-05 4 FORM 4 SUBMISSION 0001209191-22-059568 5479
2022-12-05 4 FORM 4 SUBMISSION 0001209191-22-059566 5489
2022-11-21 4 FORM 4 SUBMISSION 0001209191-22-058300 7945
2022-11-09 4 FORM 4 SUBMISSION 0001209191-22-056271 4811
2022-11-08 10-Q 10-Q 0001564590-22-037060 001-39781 221369610 34 8091637 1 1
2022-11-08 8-K 8-K 2.02,7.01,9.01 0001564590-22-037057 001-39781 221369399 34 3842670 1 1
2022-08-22 4 FORM 4 SUBMISSION 0001209191-22-046998 5133
2022-08-22 4 FORM 4 SUBMISSION 0001209191-22-046995 7945
2022-08-11 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001140361-22-026736,2022-08-11 9999999995-22-002331 333-256998 221157622 33 1685
2022-08-09 10-Q 10-Q 0001564590-22-028784 001-39781 221149031 34 7692287 1 1
2022-08-09 8-K 8-K 2.02,7.01,9.01 0001564590-22-028771 001-39781 221148732 34 4279472 1 1
2022-07-28 UPLOAD filename1.pdf 0000000000-22-007912 39585
2022-07-22 10-K/A 10-K/A 0001564590-22-026266 001-39781 221100410 34 336224 1 1
2022-07-22 POS AM POS AM 0001140361-22-026736 333-256998 221100340 33 55464
2022-07-22 CORRESP filename1.htm 0001140361-22-026730 16892
2022-07-19 8-K 8-K 5.02,9.01 0001564590-22-025922 001-39781 221089970 34 350356 1 1
2022-07-14 UPLOAD filename1.pdf 0000000000-22-007411 44013
2022-07-06 8-K 8-K 5.02 0001564590-22-025392 001-39781 221069467 34 163662 1 1
2022-06-30 8-K 8-K 7.01,9.01 0001564590-22-024914 001-39781 221057345 34 199139 1 1
2022-06-21 8-K 8-K 5.07 0001564590-22-023707 001-39781 221027015 34 192818 1 1
2022-06-15 4 FORM 4 SUBMISSION 0001209191-22-036884 7174
2022-06-08 4 FORM 4 SUBMISSION 0001209191-22-034983 5129
2022-05-19 4 FORM 4 SUBMISSION 0001209191-22-030394 7944
2022-05-17 4 FORM 4 SUBMISSION 0001209191-22-029542 7887
2022-05-17 4 FORM 4 SUBMISSION 0001209191-22-029541 5129
2022-05-16 4 FORM 4 SUBMISSION 0001209191-22-029092 5130
2022-05-16 4 FORM 4 SUBMISSION 0001209191-22-029091 5207
2022-05-10 10-Q 10-Q 0001564590-22-019294 001-39781 22910071 34 6926651 1 1
2022-05-10 8-K 8-K 2.02,7.01,9.01 0001564590-22-019285 001-39781 22909881 34 3429073 1 1
2022-04-28 DEFA14A DEFA14A 0001140361-22-016465 001-39781 22865481 34 4195577
2022-04-28 DEF 14A DEF 14A 0001140361-22-016463 001-39781 22865471 34 2654130
2022-03-04 4 FORM 4 SUBMISSION 0001209191-22-016327 5148
2022-03-03 4 FORM 4 SUBMISSION 0001209191-22-015227 5148
2022-03-01 4 FORM 4 SUBMISSION 0001209191-22-014395 7860
2022-02-25 S-3ASR S-3ASR 0001140361-22-006833 333-263047 22681294 33 2159178
2022-02-25 POS AM POS AM 0001140361-22-006798 333-256998 22679575 33 1247380
2022-02-25 S-8 FORM S-8 0001140361-22-006795 333-263025 22679501 33 863866
2022-02-25 10-K 10-K 0001564590-22-007077 001-39781 22678320 34 29200190 1 1
2022-02-25 4 FORM 4 SUBMISSION 0001209191-22-013012 7944
2022-02-24 8-K 8-K 2021 10K 2.02,7.01,9.01 0001564590-22-006755 001-39781 22672162 34 5159520 1 1
2022-02-16 424B3 424B3 0001564590-22-005261 333-256998 22640415 33 304202
2022-02-15 8-K 8-K 7.01,9.01 0001564590-22-005256 001-39781 22640222 34 427183 1 1
2022-02-14 SC 13G/A SC 13GA 0001140361-22-005357 005-91923 22634189 34 348930
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-022541 005-91923 22630451 34 159070
2022-02-11 SC 13G SEC SCHEDULE 13G 0001422849-22-000023 005-91923 22619680 34 18120
2022-02-10 SC 13G/A SC 13G/A 0001193125-22-034518 005-91923 22614447 34 71433
2022-02-03 5 FORM 5 SUBMISSION 0001209191-22-006972 9796
2022-02-03 5 FORM 5 SUBMISSION 0001209191-22-006967 6694
2022-02-03 5 FORM 5 SUBMISSION 0001209191-22-006963 10196
2022-02-03 5 FORM 5 SUBMISSION 0001209191-22-006960 5658
2021-12-10 4 FORM 4 SUBMISSION 0001209191-21-069084 7437
2021-12-10 4/A FORM 4/A SUBMISSION 0001209191-21-068976 5748
2021-12-10 4 FORM 4 SUBMISSION 0001209191-21-068956 8597
2021-12-10 4 FORM 4 SUBMISSION 0001209191-21-068955 9161
2021-12-09 4 FORM 4 SUBMISSION 0001209191-21-068851 8929
2021-12-09 4 FORM 4 SUBMISSION 0001209191-21-068850 8015
2021-12-09 4 FORM 4 SUBMISSION 0001209191-21-068849 6786
2021-12-09 4 FORM 4 SUBMISSION 0001209191-21-068847 6759
2021-12-09 4 FORM 4 SUBMISSION 0001209191-21-068844 9899
2021-12-07 424B3 424B3 0001564590-21-059574 333-256998 211476007 33 79783
2021-12-07 8-K 8-K 5.02,9.01 0001564590-21-059570 001-39781 211475943 34 253700 1 1
2021-12-07 4 FORM 4 SUBMISSION 0001209191-21-068291 4442
2021-12-07 3 FORM 3 SUBMISSION 0001209191-21-068290 2842
2021-12-07 424B3 424B3 0001564590-21-059459 333-256998 211474109 33 78603
2021-12-03 4/A FORM 4/A SUBMISSION 0001209191-21-067941 10157
2021-12-03 8-K 8-K 7.01,9.01 0001564590-21-059298 001-39781 211469484 34 251485 1 1
2021-12-02 4 FORM 4 SUBMISSION 0001209191-21-067491 9897
2021-11-22 4 FORM 4 SUBMISSION 0001209191-21-066133 8973
2021-11-15 4 FORM 4 SUBMISSION 0001209191-21-064378 7154
2021-11-15 4 FORM 4 SUBMISSION 0001209191-21-064377 5183
2021-11-12 424B3 424B3 0001564590-21-056390 333-256998 211399023 33 3404477
2021-11-10 10-Q 10-Q 0001564590-21-056205 001-39781 211396835 34 9864121 1 1
2021-11-09 8-K 8-K 2.02,7.01,9.01 0001564590-21-055806 001-39781 211393084 34 5111262 1 1
2021-11-04 424B3 424B3 0001564590-21-054537 333-256998 211380659 33 71370
2021-11-04 8-K 8-K 7.01,9.01 0001564590-21-054498 001-39781 211380215 34 197450 1 1
2021-09-24 4 FORM 4 SUBMISSION 0001209191-21-057522 2947
2021-09-23 424B3 424B3 0001564590-21-048633 333-256998 211270500 33 74076
2021-09-23 8-K 8-K 8.01,9.01 0001564590-21-048621 001-39781 211270403 34 201890 1 1
2021-09-15 424B3 424B3 0001564590-21-048051 333-256998 211255931 33 64810
2021-09-15 8-K 8-K 8.01,9.01 0001564590-21-048042 001-39781 211255684 34 193400 1 1
2021-09-15 4 FORM 4 SUBMISSION 0001209191-21-056163 8656
2021-09-03 4 FORM 4 SUBMISSION 0001209191-21-054749 7059
2021-09-02 4 FORM 4 SUBMISSION 0001209191-21-054543 8986
2021-08-17 4 FORM 4 SUBMISSION 0001209191-21-051985 5149
2021-08-17 424B3 424B3 0001564590-21-044931 333-256998 211183572 33 3037844
2021-08-13 10-Q 10-Q 0001564590-21-044327 001-39781 211172663 34 8282814 1 1
2021-08-12 8-K 8-K 2.02,7.01,9.01 0001564590-21-044061 001-39781 211168797 34 4917111
2021-07-15 424B3 424B3 0001564590-21-036745 333-256998 211092991 33 73470
2021-07-13 8-K 8-K 8.01,9.01 0001564590-21-036460 001-39781 211088168 34 111951
2021-06-25 424B3 424B3 NO.1 0001564590-21-034607 333-256998 211048355 33 74785
2021-06-22 4 FORM 4 SUBMISSION 0000899243-21-025366 5998
2021-06-22 4 FORM 4 SUBMISSION 0000899243-21-025357 8887
2021-06-22 4 FORM 4 SUBMISSION 0001209191-21-042496 18205
2021-06-22 424B3 424B3 0001193125-21-196310 333-256998 211035940 33 563706
2021-06-21 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-06-21 16:00:00 9999999995-21-002431 333-256998 211032945 33 1672
2021-06-21 8-K 8-K 5.07 0001564590-21-033639 001-39781 211031157 34 67810
2021-06-17 CORRESP filename1.htm 0001193125-21-193163 8091
2021-06-16 4 FORM 4 SUBMISSION 0000899243-21-024295 10357
2021-06-16 UPLOAD filename1.pdf 0000000000-21-007466 40115
2021-06-10 S-1 S-1 0001193125-21-187930 333-256998 211008982 33 682702
2021-06-10 4 FORM 4 SUBMISSION 0000899243-21-022994 5039
2021-06-10 4 FORM 4 SUBMISSION 0000899243-21-022993 7389
2021-06-10 4 FORM 4 SUBMISSION 0000899243-21-022990 8384
2021-06-10 4 FORM 4 SUBMISSION 0000899243-21-022989 6192
2021-06-10 4 FORM 4 SUBMISSION 0000899243-21-022987 4810
2021-06-10 4 FORM 4 SUBMISSION 0000899243-21-022988 5493
2021-06-09 4 FORM 4 SUBMISSION 0000899243-21-022899 12526
2021-06-09 4 FORM 4 SUBMISSION 0000899243-21-022894 12006
2021-05-17 8-K/A 8-K/A 2.02,7.01,9.01 0001564590-21-028375 001-39781 21930392 34 7414683
2021-05-14 10-Q 10-Q 0001564590-21-028008 001-39781 21924546 34 6388220 1 1
2021-05-13 8-K 8-K 2.02,7.01,9.01 0001564590-21-027597 001-39781 21920113 34 7404964
2021-04-28 DEFA14A DEFA14A 0001140361-21-014741 001-39781 21864137 34 891476
2021-04-28 DEF 14A DEF 14A 0001140361-21-014738 001-39781 21864084 34 2040630
2021-04-23 4 FORM 4 SUBMISSION 0000899243-21-016935 7117
2021-04-01 8-K 8-K 8.01,9.01 0001193125-21-103256 001-39781 21796048 34 26908
2021-03-30 10-K 10-K 0001564590-21-016713 001-39781 21787617 34 12141783
2021-03-29 8-K 8-K 2.02,7.01,9.01 0001564590-21-016135 001-39781 21782003 34 10601274
2021-03-02 8-K 8-K 8.01 0001193125-21-064713 001-39781 21701438 34 21353
2021-02-16 SC 13G SC 13G 0001193125-21-044913 005-91923 21638793 34 72500
2021-02-16 SC 13G/A AMENDMENT NO. 2 0001387131-21-002342 005-91923 21631284 34 238883
2021-02-09 SC 13G SC 13G 0001104659-21-016301 005-91923 21603864 34 225378
2021-02-05 3 FORM 3 SUBMISSION 0000899243-21-005107 13678
2020-12-28 SC 13D ABCELLERA BIOLOGICS INC. SCHEDULE 13D 0001068238-20-000249 005-91923 201418873 34 382776
2020-12-28 SC 13G/A AMENDMENT TO FORM SC 13G 0001387131-20-011672 005-91923 201414190 34 172247
2020-12-21 SC 13G ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-20-011461 005-91923 201405215 34 171269
2020-12-17 4 FORM 4 SUBMISSION 0001209191-20-064259 24671
2020-12-17 3/A FORM 3/A SUBMISSION 0001209191-20-064258 17972
2020-12-17 4 FORM 4 SUBMISSION 0000899243-20-034355 44658
2020-12-17 4 FORM 4 SUBMISSION 0000899243-20-034349 18099
2020-12-17 4 FORM 4 SUBMISSION 0000899243-20-034341 9709
2020-12-17 4 FORM 4 SUBMISSION 0000899243-20-034342 14514
2020-12-17 4 FORM 4 SUBMISSION 0000899243-20-034340 20195
2020-12-17 4 FORM 4 SUBMISSION 0000899243-20-034339 12322
2020-12-15 S-8 S-8 0001193125-20-317281 333-251341 201387880 33 133756
2020-12-14 424B4 424B4 0001193125-20-316986 333-250838 201386483 33 6694680
2020-12-11 3 FORM 3 SUBMISSION 0001209191-20-063107 16014
2020-12-11 3 FORM 3 SUBMISSION 0000899243-20-033648 20958
2020-12-11 3 FORM 3 SUBMISSION 0000899243-20-033647 14362
2020-12-11 3 FORM 3 SUBMISSION 0000899243-20-033646 14324
2020-12-11 3 FORM 3 SUBMISSION 0000899243-20-033645 12330
2020-12-11 3 FORM 3 SUBMISSION 0000899243-20-033644 13246
2020-12-11 3 FORM 3 SUBMISSION 0000899243-20-033643 9393
2020-12-11 3 FORM 3 SUBMISSION 0000899243-20-033642 13285
2020-12-11 3 FORM 3 SUBMISSION 0000899243-20-033641 15818
2020-12-11 3 FORM 3 SUBMISSION 0000899243-20-033640 3793
2020-12-11 CERT 8A_Cert_ABCL.pdf 0001354457-20-000780 001-39781 201382516 34 223401
2020-12-10 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-12-10 16:00:00 9999999995-20-003483 333-250838 201382142 33 1672
2020-12-10 S-1MEF S-1MEF 0001193125-20-315173 333-251280 201382054 33 64088
2020-12-10 SEC STAFF LETTER filename1.pdf 9999999997-20-005704 396713
2020-12-10 S-1/A AMENDMENT NO. 3 TO FORM S-1 0001193125-20-314458 333-250838 201379566 33 6816837
2020-12-08 8-A12B 8-A12B 0001193125-20-312822 001-39781 201375847 34 14276
2020-12-08 CORRESP filename1.htm 0001193125-20-312816 11652
2020-12-08 CORRESP filename1.htm 0001193125-20-312808 8931
2020-12-07 S-1/A AMENDMENT NO. 2 TO FORM S-1 0001193125-20-311091 333-250838 201371255 33 9621414
2020-12-03 CORRESP filename1.htm 0001193125-20-308858 42230
2020-12-02 UPLOAD filename1.pdf 0000000000-20-011523 48595
2020-11-30 CORRESP filename1.htm 0001193125-20-304879 84489
2020-11-25 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001193125-20-302988 333-250838 201346803 33 6754980
2020-11-20 CORRESP filename1.htm 0001193125-20-299512 39962
2020-11-20 S-1 S-1 0001193125-20-299507 333-250838 201333182 33 8515441
2020-11-20 UPLOAD filename1.pdf 0000000000-20-011124 51149
2020-11-12 SEC STAFF LETTER filename1.pdf 9999999997-20-005346 398375
2020-11-06 DRSLTR filename1.htm 0000950123-20-011018 65143
2020-11-06 DRS/A filename1.htm 0000950123-20-011017 377-03630 201295334 33 8631145
2020-11-02 UPLOAD filename1.pdf 0000000000-20-010344 62070
2020-10-05 DRS filename1.htm 0000950123-20-010081 377-03630 201222151 33 4994436
2020-05-27 D xslFormDX01/primary_doc.xml 06b 0001567619-20-011193 021-367729 20913744 33 9037
2018-08-10 D xslFormDX01/primary_doc.xml 06b 0001567619-18-000363 021-318995 181008664 33 7556
2018-03-19 D xslFormDX01/primary_doc.xml 06b 0001140361-18-014018 021-308029 18698569 33 6908
2017-04-06 D xslFormDX01/primary_doc.xml 06b 0001140361-17-015051 021-284172 17744104 33 6992

Latest XBRL company facts

One latest value per concept from companyfacts (262 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 326.62M 2026-11-04 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
dei EntityPublicFloat Entity Public Float USD 789.23M 2025-06-30 2025 FY 10-K 2026-02-24 0001703057-26-000012
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 2.94M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001703057-26-000020
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.68M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001703057-26-000020
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 119.92 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001703057-26-000020
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 7.27M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001703057-26-000020
ecd PeoTotalCompAmt PeoTotalCompAmt USD 6.29M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001703057-26-000020
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 8.5 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001703057-26-000020
ffd NetFeeAmt NetFeeAmt USD 27,620 2026-08-13 424B5 2026-08-13 0001193125-26-349333
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 200.00M 2026-08-13 424B5 2026-08-13 0001193125-26-349333
ffd TtlFeeAmt TtlFeeAmt USD 27,620 2026-08-13 424B5 2026-08-13 0001193125-26-349333
ffd TtlOfferingAmt TtlOfferingAmt USD 200.00M 2026-08-13 424B5 2026-08-13 0001193125-26-349333
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-13 424B5 2026-08-13 0001193125-26-349333
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-13 424B5 2026-08-13 0001193125-26-349333
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 13.73M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap AccountsPayableAndOtherAccruedLiabilities Accounts Payable and Other Accrued Liabilities USD 35.71M 2023-09-30 2023 Q3 10-Q 2023-11-02 0001703057-23-000040
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 35.44M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 2.80M 2021-06-30 2021 Q2 10-Q 2021-08-13 0001564590-21-044327
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 15.04M 2023-06-30 2023 Q2 10-Q 2023-08-03 0001703057-23-000022
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 0 2022-12-31 2022 FY 10-K 2023-02-21 0001564590-23-002128
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 3.09M 2023-12-31 2023 FY 10-K 2024-02-20 0001703057-24-000019
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 27.03M 2023-09-30 2023 Q3 10-Q 2023-11-02 0001703057-23-000040
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -3.42M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 238.56M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 11.67M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 35.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables Allowance for Doubtful Accounts, Premiums and Other Receivables USD 0 2024-12-31 2024 FY 10-K 2025-02-27 0001628280-25-008689
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 2.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 76.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap Assets Assets USD 1.50B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap AssetsCurrent Assets, Current USD 876.16M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap AssetsNoncurrent Assets, Noncurrent USD 623.71M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 600.62M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 22.60M 2020-12-31 2021 FY 10-K 2022-02-25 0001564590-22-007077
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 0 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap BusinessCombinationContingentConsiderationLiabilityNoncurrent Business Combination, Contingent Consideration, Liability, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-02-27 0001628280-25-008689
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 33.30M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-25 0001564590-22-007077
us-gaap Cash Cash USD 99.30M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 163.80M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 764.42M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 188.80M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 190.76M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 35.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 29.30M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 326.33M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 326.33M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap CommonStockValue Common Stock, Value, Issued USD 996.19M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -138.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 13.00M 2024-06-30 2024 Q2 10-Q 2024-08-06 0001628280-24-035248
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 83.09M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 35.04M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 48.05M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 16.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -30.04M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD -201,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD -30.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent Deferred Compensation Share-based Arrangements, Liability, Classified, Noncurrent USD 4.30M 2020-12-31 2021 FY 10-K 2022-02-25 0001564590-22-007077
us-gaap DeferredCompensationShareBasedArrangementsLiabilityCurrent Deferred Compensation Share-based Arrangements, Liability, Current USD 4.27M 2020-12-31 2021 FY 10-K 2022-02-25 0001564590-22-007077
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -938,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 1.96M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-20 0001703057-24-000019
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 87.72M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 9.12M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 21.24M 2023-12-31 2023 FY 10-K 2024-02-20 0001703057-24-000019
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 134.83M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 27.85M 2022-12-31 2022 FY 10-K 2023-02-21 0001564590-23-002128
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 34.06M 2022-12-31 2022 FY 10-K 2023-02-21 0001564590-23-002128
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 2.13M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 4.80M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 1.06M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 56.05M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 56.23M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 9.12M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 8.64M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 11.74M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap DeferredTaxLiabilitiesOtherFiniteLivedAssets Deferred Tax Liabilities, Other Finite-Lived Assets USD 2.01M 2022-12-31 2022 FY 10-K 2023-02-21 0001564590-23-002128
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 30.59M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap Depreciation Depreciation USD 17.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 16.05M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001703057-25-000025
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 20.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap Dividends Dividends USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap DividendsCash Dividends, Cash USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.45 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.45 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.175 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.27 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.069 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.066 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 18.23M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.034 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlements Effective Income Tax Rate Reconciliation, Tax Settlement, Percent pure 0.5 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001628280-25-008689
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -847,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 7.80M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap EquityMethodInvestmentDividendsOrDistributions Proceeds from Equity Method Investment, Distribution USD 30.11M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap EquitySecuritiesFvNiCurrentAndNoncurrent EquitySecuritiesFvNiCurrentAndNoncurrent USD 16.50M 2024-09-30 2024 Q3 10-Q 2024-11-04 0001628280-24-045026
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueAmount Equity Securities without Readily Determinable Fair Value, Amount USD 26.40M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount USD 6.10M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount USD 200,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-10 0001564590-22-019294
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-10 0001564590-22-019294
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 33.73M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths Finite-Lived Intangible Assets, Amortization Expense, Next Rolling Twelve Months USD 3.73M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001703057-25-000025
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 4.01M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 10.43M 2022-03-31 2022 Q1 10-Q 2022-05-10 0001564590-22-019294
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Five USD 2.98M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001703057-25-000025
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Four USD 3.73M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001703057-25-000025
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Three USD 3.73M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001703057-25-000025
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two USD 3.73M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001703057-25-000025
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 2.61M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 3.26M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 4.01M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 4.01M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 72.12M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 17.91M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -855,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-25 0001564590-22-007077
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 83.23M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap Goodwill Goodwill USD 47.81M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 16.31M 2021-01-01 2021-12-31 2022 FY 10-K 2023-02-21 0001564590-23-002128
us-gaap GoodwillImpairedAccumulatedImpairmentLoss Goodwill, Impaired, Accumulated Impairment Loss USD 0 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap GovernmentAssistanceAmount GovernmentAssistanceAmount USD 118.18M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-07 0001628280-24-021159
us-gaap GovernmentAssistanceAmountCumulative GovernmentAssistanceAmountCumulative USD 24.38M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap GovernmentAssistanceAmountCumulativeCurrent GovernmentAssistanceAmountCumulativeCurrent USD 16.86M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap GovernmentAssistanceAmountCumulativeNoncurrent GovernmentAssistanceAmountCumulativeNoncurrent USD 7.52M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap GovernmentAssistanceLiability GovernmentAssistanceLiability USD 188.49M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap GovernmentAssistanceLiabilityCurrent GovernmentAssistanceLiabilityCurrent USD 8.22M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap GovernmentAssistanceLiabilityNoncurrent GovernmentAssistanceLiabilityNoncurrent USD 180.28M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 8.40M 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-27 0001628280-25-008689
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -188.46M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -151.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 10.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 1.70M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001628280-25-008689
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 11.02M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap IncomeTaxesReceivableNoncurrent Income Taxes Receivable, Noncurrent USD 17.40M 2023-06-30 2023 Q2 10-Q 2023-08-03 0001703057-23-000022
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -11.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 12.32M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -54.11M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 11.86M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 252,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD 774,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 6.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -13.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD -4.97M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001703057-26-000028
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 66.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap IncreaseDecreaseInIncomeTaxesReceivable Increase (Decrease) in Income Taxes Receivable USD -19.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -3.06M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-21 0001564590-23-002128
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -4.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD -1.69M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-21 0001564590-23-002128
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD -13.10M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001703057-26-000028
us-gaap IncreaseDecreaseInRoyaltiesPayable Increase (Decrease) in Royalties Payable USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-04 0001628280-24-045026
us-gaap IncrementalCommonSharesAttributableToConversionOfPreferredStock Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock shares 63.26M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-21 0001564590-23-002128
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001628280-25-008689
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 38.39M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 10.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap InventoryNet Inventory, Net USD 7.57M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 3.64M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001703057-26-000028
us-gaap InvestmentInterestRate Investment Interest Rate pure 0.01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures USD 63.84M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 108.20M 2024-06-30 2024 Q2 10-Q 2024-08-06 0001628280-24-035248
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 160.41M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 14.24M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 14.86M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 14.87M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 14.74M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 14.16M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap Liabilities Liabilities USD 437.36M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.50B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap LiabilitiesCurrent Liabilities, Current USD 70.47M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 366.89M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 190,000 2020-12-31 2021 Q3 10-Q 2021-11-10 0001564590-21-056205
us-gaap MarketableSecurities Marketable Securities USD 500.00M 2022-12-31 2022 FY 10-K 2023-02-21 0001564590-23-002128
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 800,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 214.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -197.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 19.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -139.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -139.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -139.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 423,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-14 0001564590-21-028008
us-gaap NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 Noncash or Part Noncash Acquisition, Intangible Assets Acquired USD 9.06M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-21 0001564590-23-002128
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 22.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap OperatingExpenses Operating Expenses USD 196.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -173.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 11.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 143.22M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 5.69M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 128.13M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 130.01M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 5.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.06 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap OtherAssetsCurrent Other Assets, Current USD 68.77M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 63.62M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD 813,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 10.44M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -5.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -2.71M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 2.55M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-25 0001564590-22-007077
us-gaap PaymentsForProceedsFromLoansReceivable Payments for (Proceeds from) Loans Receivable USD -33.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 799,000 2020-01-01 2020-03-31 2021 Q1 10-Q 2021-05-14 0001564590-21-028008
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-20 0001703057-24-000019
us-gaap PaymentsToAcquireEquityMethodInvestments Payments to Acquire Equity Method Investments USD 7.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001628280-25-008689
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 5.03M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-13 0001564590-21-044327
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 624.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 7.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 33.82M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-21 0001564590-23-002128
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 4.92M 2021-06-30 2021 Q2 10-Q 2021-08-13 0001564590-21-044327
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 2.88M 2021-12-31 2021 FY 10-K 2022-02-25 0001564590-22-007077
us-gaap ProceedsFromCollectionOfLongtermLoansToRelatedParties Proceeds from Collection of Long-term Loans to Related Parties USD 1.57M 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-056205
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 522.84M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-21 0001564590-23-002128
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 7.60M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-04 0001628280-24-045026
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 74.66M 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-21 0001564590-23-002128
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 188.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap ProceedsFromLegalSettlements Proceeds from Legal Settlements USD 36.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap ProceedsFromPaymentsForLongTermLoansForRelatedParties Proceeds from Collection of (Payments to Fund) Long-term Loans to Related Parties USD 1.78M 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-25 0001564590-22-007077
us-gaap ProceedsFromRepaymentsOfShortTermDebt Proceeds from (Repayments of) Short-term Debt USD -387,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-02-25 0001564590-22-007077
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 429.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 1.58M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-04 0001628280-24-045026
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -139.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 304.24M 2023-09-30 2023 Q3 10-Q 2023-11-02 0001703057-23-000040
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 277.21M 2023-09-30 2023 Q3 10-Q 2023-11-02 0001703057-23-000040
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 38.29M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 1.82M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-25 0001564590-22-007077
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 387,000 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-10 0001564590-21-056205
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 136.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap RestrictedCash Restricted Cash USD 26.70M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 3.12M 2022-12-31 2022 FY 10-K 2023-02-21 0001564590-23-002128
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 1.96M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 25.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 200,000 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap RestrictedInvestmentsNoncurrent Restricted Investments, Noncurrent USD 6.76M 2021-12-31 2021 FY 10-K 2022-02-25 0001564590-22-007077
us-gaap RestructuringAndRelatedCostCostIncurredToDate1 Restructuring and Related Cost, Cost Incurred to Date USD 3.20M 2023-12-31 2024 FY 10-K 2025-02-27 0001628280-25-008689
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.1 2023-10-01 2023-12-31 2024 FY 10-K 2025-02-27 0001628280-25-008689
us-gaap RestructuringReserve Restructuring Reserve USD 2.00M 2023-12-31 2024 FY 10-K 2025-02-27 0001628280-25-008689
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -168.83M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 23.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 56.00M 2026-06-30 2026 Q2 10-Q 2026-08-05 0001703057-26-000046
us-gaap RoyaltyExpense Royalty Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap SecurityDeposit Security Deposit USD 13.60M 2021-12-31 2021 FY 10-K 2022-02-25 0001564590-22-007077
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 8.76M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001703057-25-000025
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 39.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 35.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap ShortTermLeaseCommitmentAmount Short-term Lease Commitment, Amount USD 12.20M 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.06B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.1 2020-12-04 2022 FY 10-K 2023-02-21 0001564590-23-002128
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 188.82M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 942,000 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-21 0001564590-23-002128
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 10.20M 2023-12-31 2023 FY 10-K 2024-02-20 0001703057-24-000019
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 1.21M 2021-03-31 2021 Q1 10-Q 2021-05-14 0001564590-21-028008
us-gaap UnbilledReceivablesCurrent Unbilled Receivables, Current USD 62.09M 2021-06-30 2021 Q2 10-Q 2021-08-13 0001564590-21-044327
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 109,000 2020-12-31 2022 FY 10-K 2023-02-21 0001564590-23-002128
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions USD 109,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-02-21 0001564590-23-002128
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 109,000 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-21 0001564590-23-002128
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2023-12-31 2023 FY 10-K 2024-02-20 0001703057-24-000019
us-gaap VariableLeasePayment Variable Lease, Payment USD 500,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-24 0001703057-26-000012
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 308.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 308.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001703057-26-000059

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →